Medicinal From Marc Lallanilla July 17, 2023 | 10:53am A powerful and significant drug is offering new hope in the battle against Alzheimer’s disease, with scientists hailing it as a huge opportunity for patients with early-onset dementia. The innovative drug donanemab, developed by Eli Lilly, has had a successful clinical trial and is expected to … Read more
FORT LEE, NJ, July 17, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority owned subsidiary of HLB Co., Ltd., is a fully integrated biopharmaceutical company dedicated to improving treatment experiences and patient outcomes who have limited or inadequate treatment options, announced today that the US Food and Drug Administration (FDA) has accepted a new … Read more
When Akorn Pharmaceuticals closed its doors in February, hospitals across the country felt it. The Lake Forest, Ill.-based drugmaker was responsible for producing 75 generic drugs, all of which were pulled from the market when the company closed. In some cases, the company was the sole supplier of particular products. The shutdown comes amid and … Read more
![author['full_name']](https://oobketo.com/wp-content/uploads/2023/07/After-pushback-JJ-authorizes-generics-of-its-tuberculosis-drug.jpg)
Following a campaign of public pressure, Johnson & Johnson (J&J) will allow a Swiss non-profit organization to supply generic bedaquiline (Sirturo) to low- and middle-income countries for the treatment of multidrug-resistant tuberculosis (TB). The campaign accused the global pharmaceutical maker of playing patent games to prevent wider distribution of the drug in low-income countries. The … Read more
Image credits: julien Tromeur/Unsplash We have previously reported numerous studies demonstrating ketamines remarkable ability to treat even the most stubborn cases of clinical depression. Ketamine is so effective that it is even known to reduce suicidal thoughts in depressed patients. However, most of these currently available ketamine treatments have one major limitation: they cost a … Read more
Federal drug agencies and drug companies continue to report a shortage of common medications used to treat symptoms of attention-deficit/hyperactivity disorder. Stock.adobe.com photo by Alex DiStasi. Federal drug agencies and pharmaceutical companies continue to report a shortage of common drugs used to treat symptoms of attention deficit hyperactivity disorder (ADHD), even as recent studies show … Read more
Scientists have developed two new drug candidates, inspired by a traditional African psychedelic medicinal plant called ibogaine, that can potentially treat addiction and depression in mice by targeting the serotonin transporter. These compounds mimic the desirable effects of ibogaine without its side effects, and more testing is underway to explore their therapeutic potential. The targeted … Read more
Doctors fear dying patients could face more pain and suffering due to an anticipated shortage of a type of morphine. A drug called Order, a liquid form of the opioid used to treat severe pain, is expected to be stopped in Australia. It is given to people dying of cancer and suffering from other life-limiting … Read more
Cris Cantu/Getty Images A new report from the CDC shows that there has been a 276% increase of xylazine in opioid overdoses. Xylazine, a veterinary tranquilizer, is increasingly being added to street drugs to create a euphoric effect. The CDC recommends using xylazine test strips to check street drugs for contamination before use. Xylazine, also … Read more
ESPAOLA Ronnie Flores feels more comfortable on the street talking to people who use drugs than people in the hospital who are being treated for substance use disorder. As a Peer Support Specialist at Presbyterian Espaola Hospital, Flores helps individuals suffering from substance use disorders related to opioids, stimulants and alcohol. Flores, who was born … Read more
